situated in the zone of tumor invasion [1, 2] . The understanding of changes in the activities of these proteolytic enzymes that initiate carcinogenesis has led to the concept of a cascade of mutual activation of proteolytic enzymes, which determines the ongoing activation of enzymes that take part in the crucial processes of carcinogenesis [3] . These changes are initiated by the presence of active cathepsin D or pepsin, which in acidic pH, activate precursors of cysteine endopeptidases. During malignant invasion, cathepsin B is initially produced in its precursor form, and the activity of this enzyme is stimulated by cathepsin D or pepsin in a low pH. Both low pH and high pepsin activity are present in the stomach, thus providing optimal conditions for the activation of cysteine peptidase precursors. The precursor enzymes are produced within cancer cells and only after secretion to the surrounding tissues are they activated and catalyze tumor invasion [4, 5] . Of all cysteine peptidases (EC 3.4.22) mainly cathepsins B and L are involved in the metabolism of malignant tumors; these subsequently catalyze the conversion of other peptidases into their active forms, which are responsible for the degradation of normal tissues, and also for bringing about tumor invasion and metastases [5, 6] . It has been confirmed that active cathepsin B is associated with many key processes in tumor growth; this finding was achieved by measurements of its activity in tissues and serum of people hospitalized for gastric cancer [7, 8] .
Introduction
The enzymatic processes that accompany the growth of gastric cancer catalyze the destruction of normal tissues. It has been found that mostly specific proteolytic enzymes participate in such processes, produced either in the cells of the malignant tumor, or in normal cells these enzymes can be considered a marker of invasion and aggressiveness of gastric cancer.
The aim of our study was to analyze the activity of proteolytic enzymes (cysteine peptidases), and their precursors and autogenous inhibitors, in biopsies of the center of tumor, the zone of invasion, and healthy tissue of the stomach in patients with advanced diffuse type gastric cancer. Additionally, another aim was to compare the above results obtained by means of two different methods of measurement, i.e., colorimetry vs spectrofluorometry.
Patients, materials, and methods

Patients and samples
The study was carried out from January 1998 to March 2000 with the homogenates of samples of resected tissues taken from 29 patients operated on for advanced gastric cancer at the Second Department of General and Oncological Surgery, Wroclaw Medical University. The group included 21 men and 8 women, aged from 28 to 73. In 20 patients, total gastric resection was performed, and subtotal resection was done in 9. All cases were advanced gastric carcinoma, diffuse Lauren type.
After the operation, three tissue samples, about 0.5g each, were taken from the resected stomach of each patient: (a) from the center of the tumor, (b) from the border of the tumor (zone of invasion), and (c) from visually normal healthy tissues, distant from the tumor. The samples were initially washed and stored frozen in 1.0ml of normal saline at a temperature of Ϫ20∞C for about 1 month.
Sample preparation
The following measurements were made in homogenates of these tissue samples: active cysteine peptidases (CP), and their precursors (pCP) and inhibitors, the latter being measured as three forms: active inhibitors of cysteine peptidases (ICP 37 ), the total pool of inhibitors produced by the patient's tissues (ICP 80 ), and the inhibitors bound in enzyme-inhibitor complexes (DICP).
For this purpose, thawed tissue samples were homogenized for 20min in normal saline, in the proportion of 1.0g tissue in 6.0ml saline, with a homogenizer MPW-309 (Universal Laboratory Aid, Warsaw, Poland). The homogenates were centrifuged for 30min at a temperature of 4∞C, at a speed of 10000g, using a Sorvall RC-5B centrifuge (Sorvall, Hamburg, Germany). The supernatant was separated, frozen at Ϫ20∞C, and then stored at 20∞C for not longer than 1 month. When thawed, the clear solutions served for biochemical examinations.
Chemical reagents
The following reagents were used in the study: N-benzoyl-dl-arginyl--naphthylamide (BANA), benzoyl-phenyl-arginyl-aminocoumarin (Z-Phe-Arg-AMC), 7-amino-4-methylcoumarin (Mec), inhibitor E-64, and enzymes. Papain and pepsin were manufactured by Sigma (St. Louis, MO, USA); methylamine 40% solution and dimethyl sulfoxide (DMSO) were manufactured by Fluka BioChemika (Birchs, Switzerland).
Measurement of enzyme activities
In the recent literature on the subject the activities of cysteine peptidases have been measured by two equivalent methods: spectrofluorometry and colorimetry. Most of our measurements were made by the colorimetric method, but we also used spectrofluorometry to prove that the results were not dependent on the method used.
Measurement of the activity of cysteine peptidases by spectrofluorometry
The activity of cysteine peptidases was measured with a Perkin Elmer UV/VIS Spectrometer Lambda Bio 20 (Perkin Elmer, Wellesley, MA, USA). One sample contained 100µl of supernatant from the homogenized tissue, diluted with normal saline as needed according to the concentration of the enzyme; 700µl 0.4 M phosphate buffer at pH 6.0, including 4mM ethylenediamine tetraacetic acid (EDTA), 2.5 mM dithiothreitol (DTT), and 200µl diluted substrate concentrate Z-Phe-Arg-NMec, whose concentration was 40µM.
The sample was incubated at 37∞C for 60min. The reaction of hydrolysis was terminated by adding 2.0ml of 1.0mM iodoacetic acid to each sample. Fluorescence of the liberated 7-amino-4-methylcoumarin (Mec) was measured using the wavelength λ ϭ 370nm for excitation and λ ϭ 440 nm for emission. The measurements were made in regard to baseline solution, which differed from the analyzed samples in that 2.0ml of iodoacetic acid was added before the substrate. The results are given in units of activity of cysteine endopeptidases, calculated for the amount of protein appearing in the sample. One unit of enzyme activity was defined as that amount of the enzyme that would liberate 1nM of Mec per 1min, calculated for 1 mg of protein [11] .
Measurement of the activity of precursors of cysteine peptidases
To the diluted supernatant samples of tissue homogenates (50µl each), 150 µl of pepsin, diluted to 0.7mg/ml in 0.01 M acetate buffer at pH 3.0, was added. The samples were incubated at 37∞C for 60min, then 0.4 M phosphate buffer at pH 6.0, containing 4mM EDTA and 200 µl of diluted substrate concentrate ZPhe-Arg-N-Mec, whose concentration was 40µM, were added to make a volume of 1.0ml. The samples were then incubated at 37∞C for 60min and the active cysteine endopeptidases were measured as described above. The activity of the precursors was calculated as the difference between enzyme activities measured directly in the homogenate and those measured after preincubation with pepsin [4] .
Measurement of the activity of cysteine peptidases by colorimetry
To the samples of homogenate (10 µl to 100µl each) 50 µl of 0.66 mM BANA substrate was added, then 0.01M phosphate buffer at pH 6.0, containing BANA, was added, and after 12 h of preincubation at 37∞C, free -naphthylamine was measured by Barrett's method. One unit of enzyme activity of cysteine proteinases was defined as that amount of the enzyme that would liberate 1 nM of -naphthylamine per 1h, calculated for 1 mg of protein [12] .
Measurement of the activity of cysteine peptidase inhibitors by colorimetry
Before the measurement of the inhibitors of cysteine peptidases, α 2 -macroglobulin was inactivated [13] . To measure the active inhibitors of cysteine endopeptidases (ICP 37 ), the analyzed homogenate samples were incubated with papain solution, and after 30min, the amount of liberated -naphthylamine was measured. The procedure was as follows:
1. Samples of homogenate (50-µl) were incubated in 0.6ml of 0.02M phosphate buffer containing 2mM EDTA and 2mM l-cysteine at pH 6.0. Then 50 µl of papain solution in the same buffer was added, the sample was incubated at 37∞C for 10 min, and liberated -naphthylamine was calculated from the standard titration curve prepared earlier. One unit of inhibitor activity was defined as that amount of the inhibitor that would inhibit 1 unit of papain activity. 2. The total amount of inhibitors (ICP 80 ) was measured after preincubation of the samples of homogenate supernatant in glycine buffer at pH 2.0, for 20min at 80∞C. Then the activity of inhibitors of cysteine peptidases was measured in the presence of BANA substrate, as described above for the measurement of free inhibitors (ICP 37 ). 3. The activity of inhibitors bound in complexes was calculated as the difference between total and free inhibitors: DICP ϭ ICP 80 Ϫ ICP 37 [14] . The enzyme activities and the levels of inhibitors were calculated for 1mg of protein [13, 14] .
The concentration of protein in the analyzed samples was measured by a method using Bradford's reagent, where pure bovine albumin was taken as the standard [15] .
Results
The measurements of these enzymatic markers of tumor growth enabled us to compare the individual differences in their activities for each patient. We compared the same parameters between patients, as well as the differences between the sampling sites in each individual patient (Tables 1 and 2 , Figs. 1-6 ). In 17 patients, the highest activities of cysteine peptidases (CP) and their precursors (pCP) and inhibitors in complexes with enzymes (DICP) were found in the homogenates of cancer tissue, whereas in the remaining 12 patients, these activities were highest in the homogenates of tissue from the zone of invasion. In the whole series, the lowest mean activities of cysteine peptidases and their precursors and enzyme-inhibitor complexes were found in the homogenates of healthy tissue (Table 1) . For the spectrofluorometric measurements, it was noted that the highest activities of cysteine peptidases and their precursors were present in cancer tissue in 22 patients, while in 7 patients they were highest in the tissue from the border of malignant growth ( Table 2) . forms of specific inhibitors of cysteine peptidases: active inhibitors, the total pool of inhibitors produced, and the inhibitors bound in enzyme-inhibitor complexes. The active inhibitors were characterized by the ability to inhibit papain, which is a cysteine peptidase. The inhibitors complexed with cysteine peptidases, which are secreted by tumor cells, we considered one of the markers of malignancy, and we referred to them as DICP [9] . Gastric cancer was intentionally selected as the subject of our study, considering the acidic pH and the presence of pepsin in the stomach, which can activate the precursors of cysteine peptidases to the active form [4] . We surmise that the observed differences between the tissues sampled from the tumor mass, the zone of invasion, and the normal tissue within the same patient with gastric cancer result from the action of pepsin at low pH, which directly affects the tissues in which the malignant tumor is growing, thus catalyzing the transformation of cathepsin B and L precursors to the active enzymes, which in turn, enhances the tumor's invasiveness. Our results for the measured activities of CP, pCP, and DICP suggest that these parameters may prove to be a useful diagnostic tool for evaluating the dynamics of malignant growth within the tissues of gastric cancer. In the future, these parameters may play some role in the designing of the extent of the operation. To elucidate this we are planning a similar study 
Discussion
The reported relationships between selected proteolytic enzymes and the aggressiveness of malignant tumors indicated possible changes in the activities of cysteine peptidases and their autogenous inhibitors in the homogenates of tissues obtained from patients operated on for gastric cancer. To date, cathepsins B and L have usually been measured by enzyme-linked immunosorbent assay (ELISA) in the tissues and serum of patients with gastrointestinal cancers [16] . Such assessments of cathepsins B and L in tissues resected during operations for gastric cancer had shown maximum concentration in the tumor mass, while in the surrounding healthy tissue these enzymes were less abundant. This confirmed the previous assumptions that cysteine peptidases may play a key role in the processes accompanying malignant growth. Our study was intended to provide supplementary information on changes in enzymatic activity in tumor growth. The measurements of precursors of cathepsins B and L provided information about the potential of malignant tumor expansion. Activation of these precursors is an indicator of enhanced potential of tumor growth. On the other hand, the activity of inhibitors of these enzymes indicates the organism's defense ability against cancer. In the samples analyzed in this study, we measured three with respect to bioptates taken endoscopically before the operation. Other important information implied by previous studies is that there may be some possibility of treating gastric cancer with specific inhibitors of cysteine peptidases, isolated from egg white. So far we have been able to demonstrate the inhibition of cysteine peptidases which initiate the growth of gastric cancer only in vitro, in homogenates of tissues sampled from resected material after operation [17] . The information that cysteine peptidase inhibitors isolated from egg whites are able to inhibit the elevated activity of cysteine endopeptidases in gastric cancer cells suggests that these inhibitors might be used as a component of newgeneration drugs in so-called "inhibitor therapy" [18] . These inhibitors have been proved nontoxic and may be administered orally. In addition, there is a possibility of labelling them with fluorescent agents approved for medical use, which might be helpful in UV evaluation of the extent of malignant infiltration [19] . There are also prospects for introducing a new method of therapy that would consist of cysteine proteinase inhibitor therapy combined with photodynamic therapy [20] .
Moreover, antibodies against these inhibitors may be used for detecting the activity of cysteine peptidases in preoperative endoscopic bioptates, which could be helpful in planning the extent of the operation [21] . In 2002 we found that, in tissue cultures of malignant tumors, cysteine peptidase inhibitors labelled with radioactive iodine reacted selectively, only with cancer cells [22] . So far these investigations have been limited to in vitro experiments, but at the moment we are preparing a series of experiments which might allow further studies in vivo, at first on animals; we hope that in the future, such studies could be carried out in gastric cancer patients.
Conclusions
Local activities of cysteine peptidases and their in-
hibitors reflect the topographical differences between the center of the tumor, the zone of invasion, and healthy tissues in gastric cancer patients. 2. The findings of the pattern of changes in the activity of cysteine peptidases according to the degree of tissue infiltration are not dependent on the method of measurement (colorimetry vs spectrofluorometry).
